Resultados de la búsqueda 81-90 of 3377 for ⚡[광고텔레:SEOGOT] 대포폰광고 백링크업체 해외선물솔루션 달림폰판매 언더키워드 웹문서작업업체⚡

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    PARPs are proteins that help repair DNA mutations. PARP inhibitors, such as olaparib, can keep PARP from working, so tumor cells can't repair themselves, and ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) versus the ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phone teleconference. We will survey patients at baseline and then at pre-specified timepoints up to 2 years after CAR-T. Survey questionnaires that have ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    TTF is currently under study for treatment of CNS parenchymal metastases, lung and pancreatic cancer. There is potential application for symptomatic ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... phone teleconference. We will survey patients at baseline and then at pre-specified timepoints up to 2 years after CAR-T. Survey questionnaires that have ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing neurocognitive ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...